Navigate Up

UPMC/University of Pittsburgh Schools of the Health Sciences
Senior Manager
Telephone: 412-578-9193 or 412-624-3212

UPMC Experts

Naftali Kaminski

UPMC Media Relations 

Simmons Center for Interstitial Lung Diseases at the University of Pittsburgh Receives $2 Million Research Grant to Study the Genomics of Idiopathic Pulmonary Fibrosis

PITTSBURGH, August 25, 2003 Scientists at the Simmons Center for Interstitial Lung Disease in the division of pulmonary, allergy and critical care medicine at the University of Pittsburgh School of Medicine, have received a $2 million research grant to study the genomics of idiopathic pulmonary fibrosis (IPF).

IPF affects nearly 100,000 people in the United States. It is a progressive interstitial lung disease of unknown origin that causes lung scarring. Scarring leads to stiffening of the lungs and inhibits their ability to provide oxygen to other tissues. This makes it more difficult to take a breath and prevents the lungs from supplying the body with enough oxygen. The average patient lives four to six years after diagnosis, although younger patients may live longer.

"This research grant will enable us to apply the information derived from the human genome project to better understand pulmonary fibrosis and find new targets for therapeutic intervention in IPF," said Naftali Kaminski, M.D., the director of the Simmons Center and director of the Functional Genomic Resource Center in the division of pulmonary, allergy and critical care medicine at the University of Pittsburgh School of Medicine. Dr Kaminski is also the Dorothy P. and Richard P. Simmons Professor of Interstitial Lung Disease at the University of Pittsburgh School of Medicine.

The investigators plan to utilize microarray technology to profile the behavior games allowing them to identify gene expression patterns that distinguish IPF from normal lung tissue and from other interstitial lung diseases. The investigators will also use advanced technologies like laser capture microdissection to identify abnormal genes in single cells obtained from lungs of patients with IPF.

"This approach may revolutionize our understanding and treatment of IPF," said Dr. Kaminski. "However it is dependent on our ability to enroll patients and get lung samples from patients with interstitial lung diseases, such as IPF, who undergo lung biopsies."

Dr. Kaminski joined the University of Pittsburgh in 2002. He pioneered the application of microarray technology for lung fibrosis research and has applied this technology in a variety of models and disease states. He has also been actively involved in developing bioinformatic approaches to the analysis of microarray data and in educating biologists in bioinformatics and computational biology.

The Simmons Center was established in 2001 as a result of a donation by Richard P. Simmons and the late Dorothy P. Simmons. The aim of the center is to provide a combination of comprehensive clinical care and advanced cutting edge basic research.

For additional information on the research study, or to find out if you qualify to participate, call 412-647-3156, or e-mail the Simmons Center at simmonsILD@upmc.edu.

©  UPMC | Affiliated with the University of Pittsburgh Schools of the Health Sciences
Supplemental content provided by A.D.A.M. Health Solutions. All rights reserved.

For help in finding a doctor or health service that suits your needs, call the UPMC Referral Service at 412-647-UPMC (8762) or 1-800-533-UPMC (8762). Select option 1.

UPMC is an equal opportunity employer. UPMC policy prohibits discrimination or harassment on the basis of race, color, religion, ancestry, national origin, age, sex, genetics, sexual orientation, marital status, familial status, disability, veteran status, or any other legally protected group status. Further, UPMC will continue to support and promote equal employment opportunity, human dignity, and racial, ethnic, and cultural diversity. This policy applies to admissions, employment, and access to and treatment in UPMC programs and activities. This commitment is made by UPMC in accordance with federal, state, and/or local laws and regulations.

Medical information made available on UPMC.com is not intended to be used as a substitute for professional medical advice, diagnosis, or treatment. You should not rely entirely on this information for your health care needs. Ask your own doctor or health care provider any specific medical questions that you have. Further, UPMC.com is not a tool to be used in the case of an emergency. If an emergency arises, you should seek appropriate emergency medical services.

For UPMC Mercy Patients: As a Catholic hospital, UPMC Mercy abides by the Ethical and Religious Directives for Catholic Health Care Services, as determined by the United States Conference of Catholic Bishops. As such, UPMC Mercy neither endorses nor provides medical practices and/or procedures that contradict the moral teachings of the Roman Catholic Church.

© UPMC
Pittsburgh, PA, USA UPMC.com